When it comes to the toys in the toy chest there is no better conference than ATTD and while virtual this year once again the diabetes device world is going gaga this week. Dexcom revealed more details about the G7, Medtronic released more data on hybrid closed loop and Senseonics data on their longer term sensor. As valuable as this information may be the question is does it matter all that much or perhaps put another way will it change the dynamics of the diabetes device landscape.
Our answer is no. Is the G7 the Libre killer . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.